Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
about
BCL6 modulation of acute lymphoblastic leukemia response to chemotherapySTAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemiaChildren Diagnosed as Mixed-Phenotype Acute Leukemia Didn't Benefit from the CCLG-2008 Protocol, Retrospective Analysis from Single Center.Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemiaClonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapseSurvival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology GroupIn vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaUpregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia.ETS-related gene is a novel prognostic factor in childhood acute lymphoblastic leukemia.Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas.Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis.Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.Precursor T-Cell Lymphoblastic Lymphoma Presenting as Cardiac Tamponade in a 25-Year-Old Male: A Case Report and Review of Literature.Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia.The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing].Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment.Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children.Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
P2860
Q28829626-1951C437-CF74-48EE-9AA2-D806010D6495Q33733773-86FE3086-EDBC-4FA3-AA9D-2FACD8F0614CQ34154532-80E22408-BFFD-4DAF-A348-139B3C96FD30Q34448969-70E67BC1-F52A-475E-A347-3D9874D44B65Q34766720-A554EBDC-DB42-470F-812F-99B93389AE97Q35051430-90EC883A-1465-494E-84BE-63EF63DF69A6Q35102275-0A87F186-A0F9-4031-8C1F-CB77913FA600Q35437903-AFF37C62-F2D2-458E-A62E-7278DBF97AE0Q35953635-D7A11D87-0331-4928-AC5A-D14D3DFDAC4CQ36255484-5F95A610-C8B7-4AF3-A1A5-88D8D3A7B45AQ36260233-6535B06A-4DB2-45EE-81C8-458898E0EA01Q37594153-24B7F80C-8858-4B18-840A-513EED925917Q37788239-87D59F85-04F7-457C-BBB0-51520FF69C01Q37829956-C9AFB133-5D82-4663-B864-56BBA7080A10Q39031833-0C16D651-E3AB-4A85-9EC9-0B1960C3FB58Q41581040-EC646B0D-C293-4E91-91F9-DC00D3E2DEA3Q43794676-7842221E-DC95-4266-9F65-7C74CBEC6B31Q46129905-05AD332E-2228-4F51-A758-D80A8226EF75Q46315145-4E09DBB3-DFB1-48F7-BE38-D697A6757A4CQ48505253-D3121878-49A2-4EFB-B6A9-6F778FCC5C89Q50201177-A0EBC972-3E34-405C-A426-CC961223B58FQ52887374-F025D261-772B-47F6-9100-F081D109C174Q52895804-0A377B78-0660-4FA7-8E8D-0731C8AFEE22Q53657116-D2D9E725-FC26-4CE9-B72B-EF123E251888Q55384335-6EFE74DF-BA6C-4AEF-8579-8030777C90CEQ58767159-9DBED7A6-2C49-4B7E-8487-6244982C2B4D
P2860
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@en
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@nl
type
label
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@en
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@nl
prefLabel
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@en
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@nl
P2093
P1433
P1476
Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.
@en
P2093
Beverly J Lange
L Charles Bailey
Nancy J Bunin
Susan R Rheingold
P304
P356
10.1016/S1470-2045(08)70229-8
P577
2008-09-01T00:00:00Z